- Today, UCSF, CommonSpirit Health, UC Berkeley and Propeller announced research that uses data from connected inhalers to show that exposure to ozone in the air leads to more frequent asthma symptoms.
- This is the first study to use a digital health platform to study the impact of ozone on respiratory disease. By attaching sensors to the inhalers of 287 people with asthma in California, researchers were able to track their medication use.
- When ozone concentrations in the air
Read More
Connected Inhalers
Cleveland Clinic Study: Propeller Health’s Smart Inhalers Reduces Hospitalizations, ER Visits for COPD Patients
Cleveland Clinic today released research that uses Propeller Health’s smart inhaler platform to show that digital medicines significantly reduced hospital visits for COPD patients. COPD is a term applied to a family of diseases that includes emphysema, chronic bronchitis, and emphysema due to alpha-1 antitrypsin deficiency. The research findings published in The Journal of Telemedicine and Telecare marks the first-ever research to assess the impact of a digital medicine on healthcare utilization
Read More
Propeller Health: 84% of People with Asthma May Be Using Their Inhaler Incorrectly
The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology. Traditionally, asthma medicines require that patients take two "puffs" of their inhaler to receive the prescribed dose. Recommended Asthma Inhaler GuidelinesAsthma guidelines and patient instructions for inhaled medications recommend that
Read More
Propeller, Health Vectura Partner To Develop Connected Dry-Powder Inhaler
Digital health company Propeller Health is teaming up with respiratory pharmaceutical company Vectura to develop digitally connected dry powder inhaler (“DPI”) technology inhalers integrated with Propeller's FDA-cleared digital health platform. The partnership will bring a new connected dry-powder inhaler device onto the Propeller platform. Vectura provides a range of pre-metered foil blister-based dry powder inhalers developed to meet patients’ needs in inhalation therapy. The initial focus of
Read More
Propeller Health, Aptar Partner To Develop Connected Metered Dose Inhaler
Digital health company Propeller Health is teaming up with Aptar Pharma (Aptar) to develop the world's first integrated connected metered dose inhaler (cMDI), with an integrated sensor and a novel electronic dose counter. The device is currently available for licensing and is expected to enter clinical studies later this year.
Connected Metered Dose Inhaler Development Details
Pressurized MDIs are the most common type of inhaler device on the market today, with over 600 million units
Read More
